483 AstraZeneca Pharmaceuticals LP Jan 2012

483 AstraZeneca Pharmaceuticals LP Jan 2012

Larry Austin FDA, Ifueko Osemwota FDA$119.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals LP - Mount Vernon, IN, United States facility and issued inspectional observations (via FDA 483) on 24 Jan 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Jan 2012
  • Location: Mount Vernon, United States
  • FEI: 1825662
Add To Cart